Using federal funds to provide gender-affirming care is prohibited under the budget reconciliation package known as the “One Big, Beautiful Bill Act." ...

Both CPAP and tirzepatide are acceptable treatments for comorbid obesity and OSA, with providers favoring CPAP and patients preferring tirzepatide.

Regardless of coronary artery calcium score, patients with higher social vulnerability are at increased risk for MACE.

The FDA has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a woman's risk for breast cancer.

Abdominal fat mass index was strongly associated with obstructive sleep apnea risk across demographic subgroups, including racial and BMI categories.